JSC
IDXX icon

J. Stern & Co’s Idexx Laboratories IDXX Stock Holding History

J. Stern & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.4K Sell
185
-4,501
-96% -$2.52M 0.01% 47
2026
Q1 		$2.63M Buy
4,686
+764
+19% +$490K 0.26% 29
2025
Q4 		$2.65M Sell
3,922
-7,229
-65% -$4.92M 0.23% 27
2025
Q3 		$7.12M Buy
11,151
+6,197
+125% +$3.76M 0.54% 27
2025
Q2 		$2.48M Buy
4,954
+299
+6% +$143K 0.21% 31
2025
Q1 		$1.95M Buy
4,655
+672
+17% +$292K 0.19% 30
2024
Q4 		$1.65M Buy
3,983
+663
+20% +$291K 0.16% 31
2024
Q3 		$1.68M Buy
3,320
+1,077
+48% +$523K 0.18% 28
2024
Q2 		$1.09M Buy
2,243
+1,877
+513% +$942K 0.13% 26
2024
Q1 		$198K Buy
366
+133
+57% +$72.7K 0.03% 32
2023
Q4 		$120K Buy
+233
New +$109K 0.02% 36

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

J. Stern & Co's IDXX Position: Q2 2026 in Review

J. Stern & Co reduced its Idexx Laboratories (IDXX) stake by 96% in Q2 2026, selling an estimated $2.52M and leaving 185 shares worth $97.4K. The position accounts for 0.01% of the portfolio, ranked #47.

J. Stern & Co first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.12M in Q3 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • J. Stern & Co held 185 shares of Idexx Laboratories worth $97.4K as of Q2 2026.
  • J. Stern & Co sold 4,501 Idexx Laboratories shares in Q2 2026, an estimated $2.52M.
  • Idexx Laboratories made up 0.01% of J. Stern & Co's portfolio in Q2 2026, its #47 holding.
  • J. Stern & Co first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • J. Stern & Co's Idexx Laboratories position peaked at $7.12M in Q3 2025.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on J. Stern & Co's 13F filing for Q2 2026, filed 14 Aug 2026.